Another Milestone for PHA Mission to Promote Awareness
With this third issue of Advances in Pulmonary Hypertension in 2007, I must first recognize the enormous success of the Pulmonary Hypertension Resource Network Symposium held in Crystal City, Virginia this October. Attendance was a record 400+ (up from 60 in 2003), and the representation was far-reaching, with attendees and participants from Oregon to Washington, DC, and Canada to Texas. This clearly reflects the tremendous interest in this growing field and speaks to the success of PHA in its mission to promote pulmonary hypertension awareness.
Associate Editor Erika Berman Rosenzweig, MD, has taken the role of Lead Editor of this issue and with Editorial Board member Kristin Highland, MD, has put together a comprehensive review of pulmonary arterial hypertension (PAH) related to congenital heart disease (CHD), with three key pieces focused on CHD. Dr Ingram Schulze-Neick provides an overview of pulmonary vascular disease in CHD, while Dr Michael Landzberg covers emerging medical therapies, and Drs Konstantinos Dimopoulos and Michael Gatzoulis teach us about how to evaluate operability in adults with CHD, as well as the role of pretreatment with targeted PAH therapy. A specialist roundtable discussion is a highlight of this issue, as it covers the practical aspects of treating patients with CHD and associated PAH. Dr Berman Rosenzweig and her contributors are to be congratulated for their efforts in producing such a wonderful issue of Advances.
Ronald J. Oudiz, MD
Editor-in-Chief
Guest Editor’s Commentary
Focusing on Pulmonary Arterial
Hypertension in Adults with
Congenital Heart Disease
This issue of Advances in Pulmonary Hypertension focuses on the
growing population of adults with congenital heart disease (CHD)
and associated pulmonary arterial hypertension (PAH). Although
progress in diagnostics and surgical intervention has dramatically
decreased the incidence of classic Eisenmenger syndrome in the
Western world, these advances have led to a rapidly growing
number of adults with CHD and associated PAH.
In this journal edition, the authors highlight some of the
considerations and challenges specific to the adult with PAH associated with CHD.
Admittedly, there are still more questions than answers for these patients; the
authors hope to bring to light some of the important issues that require further
study.
Erika Berman Rosenzweig, MD, Guest Editor
Assistant Professor of Pediatrics (in Medicine)
Division of Pediatric Cardiology
Columbia University College of Physicians and Surgeons
New York, New York
Articles
Advances in Pulmonary Hypertension,
Autumn 2007, Vol. 6, No. 3
Editor-in-Chief Ronald J. Oudiz, MD
Associate Professor of Medicine
UCLA School of Medicine
Director, Liu Center for Pulmonary Hypertension
Division of Cardiology
Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center
Torrance, California
Immediate Past Editor Vallerie V. McLaughlin, MD
Associate Professor of Medicine
Director, Pulmonary Hypertension Program
University of Michigan Health System
Ann Arbor, Michigan
Editor-in-Chief Elect Richard Channick, MD
Professor of Clinical Medicine
Pulmonary and Critical Care Division
University of California, San Diego Medical Center
San Diego, California
Associate Editors Erika Berman Rosenzweig, MD
Assistant Professor of Pediatrics
Department of Pediatrics
Columbia College of Physicians and Surgeons
New York, New York
Robert Frantz, MD
Consultant in Cardiovascular
Diseases and Internal Medicine
Assistant Professor of Medicine
Mayo Clinic College of Medicine
Rochester, Minnesota
Srinivas Murali, MD, FACC
Professor of Medicine
Drexel University College of Medicine
Director, Division of Cardiovascular Medicine
Medical Director, Gerald McGinnis Cardiovascular Institute
Allegheny General Hospital
Pittsburgh, Pennsylvania
Publisher
Pulmonary Hypertension Association
Jack Stibbs, Board Chair
Rino Aldrighetti, President
Rachel Pokorney, Medical Services Associate Director
Publishing Staff
Stu Chapman, Executive Editor
Susan Chapman, Managing Editor
Heidi Green, Associate Editor
Gloria Catalano, Production Director
Michael McClain, Design Director
Editorial Offices
Advances in Pulmonary Hypertension
DataMedica
424 Dune Road Westhampton Beach, NY 11978
Tel: 631-288-7733
Fax: 631- 288-7744
Advances in Pulmonary Hypertension is circulated to
cardiologists, pulmonologists, rheumatologists and other selected
physicians by the Pulmonary Hypertension
Association
. The contents of the
articles are
independently determined ly the Editor
and the Editorial Advisory
Board.
Editorial Mission Advances in Pulmonary Hypertension is committed
to help physicians in their clinical decision
making by informing them of important
trends affecting their practice. Analyzing the
impact of new findings and covering current
information in the peer-reviewed literature,
Advances in Pulmonary Hypertension is published
four times a year. Advances in Pulmonary
Hypertension is the official journal
of the Pulmonary Hypertension Association.
Each article in this journal has been reviewed
and approved by members of the Editorial
Advisory Board.
Editorial Board
Todd Bull, MD
Division of Pulmonary Sciences and Critical Care Medicine
University of Colorado Health Sciences Center
Denver, Colorado
Murali Chakinala, MD
Director, Pulmonary Hypertension Clinic
Washington University School of Medicine
St. Louis, Missouri
Kristin Highland, MD
Assistant Professor
Division of Pulmonary and Critical Care
Director, Pulmonary Hypertension Clinic
Medical University of South Carolina
Charleston, South Carolina
Jim Maloney, MD
Associate Professor of Pulmonary and Critical Care Medicine
University of Colorado Health Sciences Center
Denver, Colorado
Ioana Preston, MD
Assistant Professor of Medicine
Tufts - New England Medical Center
Boston, Massachusetts
Zeenat Safdar, MD
Assistant Professor of Medicine
Department of Medicine, Pulmonary & Critical Care Section
Pulmonary Hypertension Center
Baylor College of Medicine
Houston, Texas
Rajan Saggar, MD
Assistant Professor
Division of Pulmonary and Critical Care
Medicine and Hospitalists
David Geffen School of Medicine
UCLA
Los Angeles, California
Robert Schilz, DO, PhD
Medical Director of Lung
Transplantation and Pulmonary Vascular Disease
University Hospital of Cleveland
Case Western Reserve University
Cleveland, Ohio
Francisco Soto, MD, MS
Assistant Professor
Director, Pulmonary Hypertension Program
Medical College of Wisconsin
Milwaukee, Wisconsin
Roxana Sulica, MD
Assistant Professor of Medicine
Albert Einstein College of Medicine
Director, Beth Israel Pulmonary Hypertension Program
Beth Israel Medical Center
New York, New York
The
information provided on the PHA website is provided for general information
only. It is not intended as legal, medical or other professional
advice, and should not be relied upon as a substitute for consultations
with qualified professionals who are familiar with your individual
needs.
With this third issue of Advances in Pulmonary Hypertension in 2007, I must first recognize the enormous success of the Pulmonary Hypertension Resource Network Symposium held in Crystal City, Virginia this October. Attendance was a record 400+ (up from 60 in 2003), and the representation was far-reaching, with attendees and participants from Oregon to Washington, DC, and Canada to Texas. This clearly reflects the tremendous interest in this growing field and speaks to the success of PHA in its mission to promote pulmonary hypertension awareness.
